Adrenaline group

n = 35

Levosimendan group n = 28

X²/t

P-value

Age

51.45 ± 4.37

52.08 ± 5.12

0.527

0.600

Sex

Female

5

7

1.158

0.282

Male

30

21

BMI

25.5 ± 4.16

26.12 ± 5.31

0.520

0.605

Weight (kg)

73.4 ± 13.71

72.78 ± 11.7

0.190

0.849

Height (cm)

169.1 ± 8.55

168.56 ± 7.62

0.261

0.794

DM

19

12

0.813

0.367

Systemic hypertension

19

15

0.003

0.955

NYHA I

2

2

0.053

0.817

NYHA II

10

8

0.000

1.000

NYHA III

12

11

0.168

0.682

NYHA IV

11

7

0.315

0.575

Angina

5

4

0.000

1.000

Previous recent MI

10

8

0.000

1.000

EuroSCORE (range 1.11 - 6.34)

3.34 ± 1.26

3.15 ± 1.42

0.562

0.576

EF (range 25 - 39)%

29.45 ± 3.75

30.67 ± 4.28

1.628

0.109

ESD (range 3.5 - 5.5) cm

4.2 ± 1.14

3.95 ± 1.45

0.766

0.446

EDD (range 4.2 - 6.5) cm

5.13 ± 1.22

5.07 ± 1.36

0.184

0.854

Left main disease

5

5

0.149

0.700

Preoperative IABP

6

5

0.006

0.941

Preoperative inotropes

0

0

0.000

1.000

Total bypass (range 70 - 120) min

94.23 ± 5.67

95.12 ± 4.84

0.660

0.512

ACC time (range 45 - 85) min

68.37 ± 6.69

70.08 ± 5.66

1.078

0.285

Arterial grafts

1

1

0.026

0.872

Venous grafts (range 1 - 3)

1.8 ± 0.67

1.94 ± 0.43

0.958

0.342

Total grafts (range 2 - 4)

2.87 ± 1.01

3.12 ± 0.45

1.215

0.228

Postoperative AF

9

7

0.004

0.948

Postoperative ventricular arrhythmia

2

1

0.158

0.691

Need for postoperative IABP

4

1

1.314

0.252

Need for inotropes > 48 hours

10

13

2.140

0.144

Need for readministration of inotropes

7

3

1.004

0.316

Need for reintubation

4

1

1.314

0.252

Use of adjuvant adrenaline

Not applicable

20

-

-